DE69418307D1 - Verhütung und behandlung von zytomegalovirus mittels aminopeptidase - Google Patents
Verhütung und behandlung von zytomegalovirus mittels aminopeptidaseInfo
- Publication number
- DE69418307D1 DE69418307D1 DE69418307T DE69418307T DE69418307D1 DE 69418307 D1 DE69418307 D1 DE 69418307D1 DE 69418307 T DE69418307 T DE 69418307T DE 69418307 T DE69418307 T DE 69418307T DE 69418307 D1 DE69418307 D1 DE 69418307D1
- Authority
- DE
- Germany
- Prior art keywords
- prevention
- treatment
- zytomegalovirus
- aminopeptidase
- aminopeptidases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Anesthesiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US698293A | 1993-01-21 | 1993-01-21 | |
US9966493A | 1993-07-30 | 1993-07-30 | |
PCT/EP1994/000188 WO1994016724A1 (en) | 1993-01-21 | 1994-01-21 | Prevention and treatment of cytomegalovirus using aminopeptidase |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69418307D1 true DE69418307D1 (de) | 1999-06-10 |
DE69418307T2 DE69418307T2 (de) | 1999-11-04 |
Family
ID=26676317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69418307T Expired - Fee Related DE69418307T2 (de) | 1993-01-21 | 1994-01-21 | Verhütung und behandlung von zytomegalovirus mittels aminopeptidase |
Country Status (11)
Country | Link |
---|---|
US (1) | US6511662B1 (de) |
EP (1) | EP0680333B1 (de) |
JP (1) | JPH08506106A (de) |
AT (1) | ATE179613T1 (de) |
AU (1) | AU681115B2 (de) |
CA (1) | CA2154346A1 (de) |
DE (1) | DE69418307T2 (de) |
DK (1) | DK0680333T3 (de) |
ES (1) | ES2131188T3 (de) |
GR (1) | GR3030462T3 (de) |
WO (1) | WO1994016724A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2347625A1 (en) * | 1998-10-22 | 2000-04-27 | Richard A. Shimkets | Genes and proteins predictive and therapeutic for renal disease and associated disorders |
GB0700133D0 (en) | 2007-01-04 | 2007-02-14 | Humabs Llc | Human cytomegalovirus neutralising antibodies and use thereof |
US7947274B2 (en) | 2007-01-04 | 2011-05-24 | Humabs, LLC. | Human cytomegalovirus neutralising antibodies and use thereof |
GB0803076D0 (en) * | 2008-02-20 | 2008-03-26 | Univ Ghent | Mucosal Membrane Receptor and uses thereof |
PE20141434A1 (es) | 2008-07-16 | 2014-10-22 | Inst Research In Biomedicine | Anticuerpos neutralizantes de citomegalovirus humano |
-
1994
- 1994-01-21 ES ES94906142T patent/ES2131188T3/es not_active Expired - Lifetime
- 1994-01-21 EP EP94906142A patent/EP0680333B1/de not_active Expired - Lifetime
- 1994-01-21 AT AT94906142T patent/ATE179613T1/de not_active IP Right Cessation
- 1994-01-21 WO PCT/EP1994/000188 patent/WO1994016724A1/en active IP Right Grant
- 1994-01-21 JP JP6516674A patent/JPH08506106A/ja active Pending
- 1994-01-21 DK DK94906142T patent/DK0680333T3/da active
- 1994-01-21 CA CA002154346A patent/CA2154346A1/en not_active Abandoned
- 1994-01-21 DE DE69418307T patent/DE69418307T2/de not_active Expired - Fee Related
- 1994-01-21 AU AU59991/94A patent/AU681115B2/en not_active Ceased
-
1999
- 1999-06-09 GR GR990401535T patent/GR3030462T3/el unknown
-
2000
- 2000-11-28 US US09/722,376 patent/US6511662B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GR3030462T3 (en) | 1999-10-29 |
JPH08506106A (ja) | 1996-07-02 |
CA2154346A1 (en) | 1994-08-04 |
WO1994016724A1 (en) | 1994-08-04 |
ATE179613T1 (de) | 1999-05-15 |
AU5999194A (en) | 1994-08-15 |
DK0680333T3 (da) | 2000-01-03 |
DE69418307T2 (de) | 1999-11-04 |
EP0680333A1 (de) | 1995-11-08 |
EP0680333B1 (de) | 1999-05-06 |
AU681115B2 (en) | 1997-08-21 |
US6511662B1 (en) | 2003-01-28 |
ES2131188T3 (es) | 1999-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE230757T1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
MY138860A (en) | Hiv protease inhibitors. | |
ATE277612T1 (de) | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen | |
DE3588023D1 (de) | Mittel zur Behandlung von Herzerkrankungen. | |
DE69426690D1 (de) | Behandlung von atrophischer Haut und Vagina | |
ATE263761T1 (de) | 5,6-dihydropyronderivate als proteaseinhibitoren und antiviralmittel | |
DE3750934D1 (de) | Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten. | |
DE69518840D1 (en) | N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren | |
ATE439833T1 (de) | Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten | |
DE69620691D1 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
DE60035693D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
MD960172A (en) | 5,6-dihydropyrone derivatives as proteaze inhibitors and antiviral agents | |
ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
DE69418307D1 (de) | Verhütung und behandlung von zytomegalovirus mittels aminopeptidase | |
DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
ATE151774T1 (de) | Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen | |
BG102404A (en) | The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system | |
DE69718500D1 (de) | (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen | |
WO1997026880A3 (en) | Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients | |
HUP0100937A2 (hu) | Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen | |
ATE229343T1 (de) | Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs | |
ATE203680T1 (de) | Konjugat zur behandlung von entzündungserkrankungen | |
ATE255417T1 (de) | Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen | |
DE3883754D1 (de) | Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten. | |
NO982151D0 (no) | Hemoregulatoriske forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |